MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Differential Effect of alpha-Synuclein on Mitochondrial Morphology in PD and MSA

O. Driskill, E. Ostrakhovitch, J. Patel, J. Stegemann, T. Yamasaki (Lexington, USA)

Meeting: 2025 International Congress

Keywords: Alpha-synuclein, Mitochondria, Multiple system atrophy(MSA): Etiology and Pathogenesis

Category: Parkinson's Disease: Pathophysiology / molecular mechanisms of disease

Objective: In this study, we investigated the morphology of mitochondria and localization of alpha-synuclein as driven by alpha-synuclein isolated from PD and MSA brain-derived tissue.

Background: Parkinson’s disease (PD) and multiple system atrophy (MSA) are neurodegenerative movement disorders with the hallmark feature of pathologic aggregation of α-syn. There are known bioenergetic deficits in PD with known Complex I inhibition in mitochondria in the brain. MSA has also been associated with CoQ2 mutations with resultant alteration in CoQ10 biosynthesis and electron transport chain dysfunction.

Method: PD, MSA, and control (non-synucleinopathy) brain tissue was obtained from Washington University St Louis Movement Disorder brain bank. a-Syn overexpressing HEK293 cells were plated at 260,000 cells per well in a 12 well-plate and exposed to insoluble brain fractions after a 3min 65A sonication on ice (QSonica) and incubated for inclusion formation for 72 hours. Cells were then fixed in glutaraldehyde for 5min. Tissue was embedded in Epon Epoxy resin and sectioned and mounted on formar grids. Sections were stained with uranyl acetate and imaged on a Talos FEI F200X transmission electron microscope.

Results: Cells exposed to PD insoluble brain fractions uniformly demonstrated a severe and prominent deformation of the mitochondria. Mitochondria were increased in size with a ballooned appearance and demonstrated a perturbation of the cristae. Increased distance between cristae contributed to a decrease in the cristae density. In MSA-exposed cells, mitochondrial structure was much less affected, but there were striking differences. A subpopulation of mitochondria were greatly elongated in comparison to control tissue-exposed mitochondria.

Conclusion: These results demonstrate a prominent change in mitochondrial morphology in cells exposed to PD brain tissue vs those exposed to MSA brain tissue in this in vitro cell system. These findings are in line with a prominent role for mitochondrial toxicity in PD. Intriguingly, mitochondrial appearance in MSA brain tissue exposed cells was much less affected and elongated structures seen may suggest a deficiency in mitochondrial fusion/fission. These structural studies argue for different mitochondrial effects in PD and MSA. Further studies are warranted to confirm potential pathophysiologic mechanisms.

To cite this abstract in AMA style:

O. Driskill, E. Ostrakhovitch, J. Patel, J. Stegemann, T. Yamasaki. Differential Effect of alpha-Synuclein on Mitochondrial Morphology in PD and MSA [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/differential-effect-of-alpha-synuclein-on-mitochondrial-morphology-in-pd-and-msa/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/differential-effect-of-alpha-synuclein-on-mitochondrial-morphology-in-pd-and-msa/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley